Here are your intra day picks for the day from various market experts and brokerage houses :
Vishal Malkan of www.malkansview.com, has two buy recommendations. His first pick is Bata India and he recommend a buy with the stoploss of Rs 881 for targets of Rs 900 and Rs 907. The stock has been outperforming the markets for a long time and is up almost 97 percent in the last one year vs 9 percent fall in the Sensex.
His second pick is Ranbaxy as the stock has broken out of the resistance of Rs 525, started tagging upper bollinger band on daily charts coupled with the fact that momentum is high and volumes are also high in last couple of days. He recommends a buy with a stoploss of Rs 521 for targets of Rs 539 and 547.
Manas Jaiswal of manasjaiswal.com also has two picks. They are MRF and Praj Inds. He recommends buying the stock at current levels with a stop loss of Rs 10,600. He says on the weekly charts it is still making higher tops and higher bottoms and now the stock can test Rs 11,500 in the next three to four trading sessions.
Nooresh Merani of AMSEC Research, has a buy on Punjab National Bank and IDFC. He says to buy Punjab National Bank with a target price of Rs 770 and a stop loss to be placed at Rs 705. The stock has fallen from a high of Rs 1,090 in February-March to a low of Rs 700 over the last few months. The stock has seen no recovery over the last few weeks and the fall has been very steep.
The second call to buy is IDFC with a target price of of Rs 130 and a stop loss to be placed at Rs 120. The stock has closed well above Rs 123 levels and we could expect a quick move to Rs 130 in the short term.
PN Vijay, Portfolio Manager says that one can buy Jyothy Laboratories with a target of Rs 300 in the next 12 months. He says that many people don't know that it is also an FMCG company and that if compared it to other FMCG companies it is quite cheap.
Disclaimer: Views expressed above are that of various market experts only and Firstpost will not be held responsible for any investment decision based on the above recommendations.